NERV CIK: 1598646

Minerva Neurosciences, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
62.2
FY22:
40.2
FY23:
42.0
FY24:
22.3
FY25:
83.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
14.9
FY22:
14.9
FY23:
14.9
FY24:
14.9
FY25:
14.9
Total assets
Change from FY21 to FY25
millions USD
FY21:
77.1
FY22:
55.1
FY23:
56.9
FY24:
37.1
FY25:
98.0

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
2.82
FY22:
1.38
FY23:
3.34
FY24:
2.84
FY25:
2.29
(negative)
Change from FY21 to FY25
millions USD
FY21:
66.3
FY22:
73.7
FY23:
82.0
FY24:
60.0
FY25:
231
(positive)
Change from FY21 to FY25
millions USD
FY21:
7.98
FY22:
−20.0
FY23:
−28.5
FY24:
−25.7
FY25:
−141
Total liabilities & equity
Change from FY21 to FY24
millions USD
FY21:
77.1
FY22:
55.1
FY23:
56.9
FY24:
37.1
FY25:
–

All amounts in millions USD Data source:SEC EDGAR